{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:05:15Z","timestamp":1790877915136,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["24OK1078"],"award-info":[{"award-number":["24OK1078"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xkme.2026.101478","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:38:21Z","timestamp":1784356701000},"page":"101478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Contactin-1-Associated Membranous Nephropathy Presenting With Subsequent Autoimmune Nodopathy"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2885-2905","authenticated-orcid":false,"given":"Ruben","family":"Visch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Debiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Mul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Nijenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Els van de","family":"Logt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ndt\/gfp665","article-title":"Membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian population","volume":"25","author":"McQuarrie","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2026.101478_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101478_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0303-8467(92)90115-J","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy with membranous glomerulonephritis: report of one case","volume":"94","author":"Kohli","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.xkme.2026.101478_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0272-6386(96)90554-5","article-title":"Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies","volume":"27","author":"Panjwani","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101478_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.37.2.342","article-title":"Membranous glomerulonephritis associated with chronic progressive demyelinating neuropathy","volume":"37","author":"Witte","year":"1987","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101478_bib8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2026.101478_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2021.08.025","article-title":"Contactin 1, a potential new antigen target in membranous nephropathy: a case report","volume":"80","author":"Santoro","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.xkme.2026.101478_bib10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2215\/CJN.00670112","article-title":"Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy","volume":"7","author":"van den Brand","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101478_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/jns.70000","article-title":"Inter-laboratory validation of nodal\/paranodal antibody testing","volume":"30","author":"Lleixa","year":"2025","journal-title":"J Peripher Nerv Syst"},{"issue":"7","key":"10.1016\/j.xkme.2026.101478_bib12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.xkme.2026.101478_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fneur.2018.00997","article-title":"Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey","volume":"9","author":"Hashimoto","year":"2018","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib14","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\"Neuro-renal syndrome\" related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.xkme.2026.101478_bib15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype","volume":"7","author":"Cortese","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.xkme.2026.101478_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/cjn.2020.46","article-title":"Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy","volume":"47","author":"Nazarali","year":"2020","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"10.1016\/j.xkme.2026.101478_bib17","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.xkme.2026.101478_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.759187","article-title":"Characteristics of anti-contactin1 antibody-associated autoimmune nodopathies with concomitant membranous nephropathy","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101478_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.kint.2021.08.029","article-title":"Contactin-1-associated membranous nephropathy: complete immunologic and clinical remission with rituximab","volume":"100","author":"Plaisier","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nmd.2022.01.006","article-title":"Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy","volume":"32","author":"Tan","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.xkme.2026.101478_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CND.0000000000000395","article-title":"Rituximab responsive relapsing-remitting IgG4 anticontactin 1 chronic inflammatory demyelinating polyradiculoneuropathy associated with membranous nephropathy: a case description and brief review","volume":"23","author":"Remiche","year":"2022","journal-title":"J Clin Neuromuscul Dis"},{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281156","article-title":"Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis","volume":"18","author":"Fehmi","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.xkme.2026.101478_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/acn3.51754","article-title":"CIDP\/autoimmune nodopathies with nephropathy: a case series study","volume":"10","author":"Tang","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101478_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2169\/internalmedicine.2126-23","article-title":"Anti-contactin 1 antibody-associated membranous nephropathy in chronic inflammatory demyelinating polyneuropathy with several autoantibodies","volume":"63","author":"Shida","year":"2024","journal-title":"Intern Med"},{"key":"10.1016\/j.xkme.2026.101478_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578460","article-title":"Characteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy","volume":"396","author":"Liu","year":"2024","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101478_bib26","article-title":"Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy associated with anti-contactin-1 autoantibodies: a rare case report with a review of the literature","volume":"17","author":"Tarabzuni","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.xkme.2026.101478_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1549363","article-title":"Case report: pediatric age onset CNTN1 antibody-associated neuropathy with nephropathy and literature review","volume":"16","author":"Bayraktar Eltutan","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101478_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.kint.2023.06.032","article-title":"Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification","volume":"104","author":"Sethi","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101478_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.665136","article-title":"Anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy\/combined central and peripheral demyelination: strategies for diagnosis and treatment based on the disease mechanism","volume":"12","author":"Kira","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101478_bib30","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.kint.2021.09.022","article-title":"When contactin antibodies hit the podocyte: a new neurorenal syndrome","volume":"100","author":"Debiec","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2026.101478_bib31","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3389\/fimmu.2019.01809","article-title":"Immunological pathogenesis of membranous nephropathy: focus on PLA2R1 and its role","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"issue":"1-2","key":"10.1016\/j.xkme.2026.101478_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-328X(94)90372-7","article-title":"Identification and characterization of the human cell adhesion molecule contactin","volume":"21","author":"Reid","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"issue":"Pt 6","key":"10.1016\/j.xkme.2026.101478_bib33","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.xkme.2026.101478_bib34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.1988.56","article-title":"Idiopathic membranous nephropathy: the natural history of untreated patients","volume":"33","author":"Donadio","year":"1988","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.xkme.2026.101478_bib35","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"2015","author":"Mehndiratta","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xkme.2026.101478_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1475478","article-title":"Case report: target antigen and subclass switch in a patient with autoimmune nodopathy","volume":"15","author":"Appeltshauser","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101478_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.autrev.2015.10.004","article-title":"Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)","volume":"15","author":"Radice","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.xkme.2026.101478_bib38","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ekir.2024.08.033","article-title":"Combination therapy with rituximab and low-dose cyclophosphamide and prednisone in membranous nephropathy","volume":"9","author":"Vink","year":"2024","journal-title":"Kidney Int Rep"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:33:42Z","timestamp":1790876022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2590059526002402"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101478","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Contactin-1-Associated Membranous Nephropathy Presenting With Subsequent Autoimmune Nodopathy","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101478"}}